These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2731693)

  • 1. Scintigraphic demonstration of the thoracic duct following oral ingestion of 123I-heptadecanoic acid.
    Hvid-Jacobsen K; Thomsen HS; Nielsen SL; Kamper AL; Vestbo J
    Gastrointest Radiol; 1989; 14(3):212-4. PubMed ID: 2731693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of the thoracic duct by 123I heptadecanoic acid. Report of a case.
    Hvid-Jacobsen K; Nielsen SL; Jensen VJ; Thomsen HS
    Acta Radiol; 1987; 28(6):783-4. PubMed ID: 2962620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of lymphatic leakage site in chylothorax by thoracic duct scintigraphy by orally administered 123I BMIPP using SPECT/CT.
    Takanami K; Ichikawa H; Takahashi S
    Clin Nucl Med; 2012 Apr; 37(4):403-5. PubMed ID: 22391719
    [No Abstract]   [Full Text] [Related]  

  • 4. Thoracic duct scintigraphy by orally administered I-123 BMIPP: normal findings and a case report.
    Qureshy A; Kubota K; Ono S; Sato T; Fukuda H
    Clin Nucl Med; 2001 Oct; 26(10):847-55. PubMed ID: 11564922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radionuclide visualization of the thoracic lymphatic duct in patients with stomach cancer].
    Bykov SA; Kanaev SV; Mel'nikov RA; Artiushkin AV; Matveev BV
    Vopr Onkol; 1985; 31(2):36-42. PubMed ID: 3976206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scintigraphic distribution of lymphatic flow in the mediastinum after oral administration of radiolabeled lipid and its influx into blood circulation.
    Sado T; Sato M; Sagawa M; Shimada K; Okada Y; Matsumura Y; Tanita T; Kondo T
    J Thorac Cardiovasc Surg; 2001 Oct; 122(4):838-40. PubMed ID: 11581630
    [No Abstract]   [Full Text] [Related]  

  • 7. Three-dimensional lymphoscintigraphy using SPECT/CT and 123I-BMIPP for the preoperative detection of anatomical anomalies of the thoracic duct.
    Takanami K; Ichikawa H; Fukuda H; Takahashi S
    Clin Nucl Med; 2012 Nov; 37(11):1047-51. PubMed ID: 23027205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The myocardial elimination rate of radioiodinated heptadecanoic acid.
    Visser FC; Westera G; van Eenige MJ; Van der Wall EE; Den Hollander W; Roos JP
    Eur J Nucl Med; 1985; 10(3-4):118-22. PubMed ID: 3996438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scintigraphic localization of lymphatic leakage site after oral administration of iodine-123-IPPA.
    Kettner BI; Aurisch R; Rückert JC; Sandrock D; Munz DL
    J Nucl Med; 1998 Dec; 39(12):2141-4. PubMed ID: 9867158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of radionuclide examination of the thoracic duct for the determination of the operability of esophageal cancer].
    Bykov SA; Bebiia NV; Kanaev SV; Artiushkin AV
    Vestn Khir Im I I Grek; 1985 Mar; 134(3):8-12. PubMed ID: 4002527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of radioiodinated heptadecanoic acid and metabolites in the normal and ischaemic canine heart.
    Visser FC; van Eenige MJ; Westera G; den Hollander W; Roos JP
    Eur Heart J; 1985 Aug; 6 Suppl B():97-101. PubMed ID: 4085512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic fate of radioiodinated heptadecanoic acid in the normal canine heart.
    Visser FC; van Eenige MJ; Westera G; Den Hollander W; Duwel CM; van der Wall EE; Heidendal GA; Roos JP
    Circulation; 1985 Sep; 72(3):565-71. PubMed ID: 4017208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of myocardial metabolism with iodine-123 heptadecanoic acid: effect of decreased fatty acid oxidation on deiodination.
    Lüthy P; Chatelain P; Papageorgiou I; Schubiger A; Lerch RA
    J Nucl Med; 1988 Jun; 29(6):1088-95. PubMed ID: 3373317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial scintigraphy with I-123 heptadecanoic acid as a test for coronary heart disease.
    Railton R; Rodger JC; Small DR; Harrower AD
    Eur J Nucl Med; 1987; 13(2):63-6. PubMed ID: 3609054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic myocardial imaging with 123I-labeled heptadecanoic acid in patients with angina pectoris.
    van der Wall EE; Heidendal GA; den Hollander W; Westera G; Roos JP
    Eur J Nucl Med; 1981; 6(9):391-6. PubMed ID: 7274289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myocardial scintigraphy using omega-I-123 heptadecanoic acid (Rossendorf) in patients with coronary disease].
    Lohr E; Mende T; Steinbach J; Hliscs R; Anders G; Franke WG; Beyer GJ
    Cor Vasa; 1988; 30(1):18-26. PubMed ID: 3378445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lymphatic duct scintigraphy of cancer patients].
    Bykov SA; Iakovleva LA
    Med Radiol (Mosk); 1983 Sep; 28(9):57-8. PubMed ID: 6621282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radionuclide diagnosis of disorders of the central lymph dynamics in thoracic duct pathology].
    Bykov SA; Grishakov SV; Bebiia NV; Bykova GV
    Med Radiol (Mosk); 1989 Jan; 34(1):27-9. PubMed ID: 2913440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [123I-heptadecanoic acid--our initial experiences in its clinical use].
    Mende T; Lohr E; Franke WG; Steinbach J; Beyer GJ; Hliscs R
    Radiobiol Radiother (Berl); 1986; 27(1):83-8. PubMed ID: 3704134
    [No Abstract]   [Full Text] [Related]  

  • 20. [Expanded evaluation possibilities of 123I-heptadecanoic acid metabolic studies of the myocardium using parametric scintigraphy].
    Hliscs R; Franke WG; Ulrich J; Lohr E; Mende T
    Radiol Diagn (Berl); 1988; 29(3):496-8. PubMed ID: 3186967
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.